TP53 and hepatocellular carcinoma: Since 5-azacytidine is a methyltransferase inhibitor, this drug is expected to induce senescence in a p53 dependent manner as reported for oral squamous cell carcinoma, hepatocellular carcinoma cells, and other solid tumour cell lines [36].